Pliant Therapeutics Inc Capital Reinvestment Ratio

Latest as of June 2020: 0.04x

Pliant Therapeutics Inc capital reinvestment ratio. Pliant Therapeutics Inc (PLRX) has a Capital Reinvestment Ratio of 0.04x as of June 2020, meaning it reinvests 0% of its operating cash flow ($7.77 Million) in capital expenditures ($286.00K). Check Pliant Therapeutics Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.04x

Capex / Operating Cash Flow

Operating Cash Flow

$7.77 Million

USD

Capital Expenditures

$286.00K

USD

Data as of

Jun 2020

Most recent filing

Pliant Therapeutics Inc Capital Reinvestment Ratio by Year (None–None)

Pliant Therapeutics Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see PLRX cash flow metrics.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow